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Abstract
Pregnancy success requires a proper fetal maternal interaction at the establishment of implantation. Leptin has been described as a 
multitasking cytokine in pregnancy, particularly in the placenta, where it acts as an autocrine hormone. The expression of leptin in 
normal trophoblastic cells is regulated by different endogenous signals. We have previously reported that 17β-estradiol upregulates 
placental leptin expression through genomic and non-genomic mechanisms. To improve the knowledge of estrogen receptor 
mechanisms in regulating leptin gene expression, we examined transcription nuclear factor kappa B (NFκB) effect on estradiol leptin 
induction in human BeWo cell line and human term placental explants. We demonstrated that estradiol induction effect on leptin 
expression is blocked by the inhibition of NFκB signaling. We also found that the overexpression of p65 subunit, the active form of 
NFκB, induces leptin expression. Moreover, downregulation of estrogen receptor alpha (ERα), through a specific siRNA, abolished 
NFκB effect on leptin expression. We also demonstrated that ERα enhanced NFκB signaling pathway activation in trophoblastic cells. 
Estradiol treatment significantly increased p65 expression and phosphorylation of the inhibitory protein κB alpha (IκBα). A reporter 
plasmid containing NFκB elements was also induced in response to estradiol stimulation. Localization experiments revealed that 
estradiol treatment induced nuclear localization of overexpressed p65. Moreover, the overexpression of ERα produced a complete 
displacement of p65 protein to the nucleus. Finally, immunoprecipitation experiments showed the presence of a complex containing 
ERα and NFκB. All these evidences suggest a cooperative behavior between ERα and NFκB transcription factors to induce 
leptin transcription.
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Introduction
The success of pregnancy requires a time and dose 
dependent maternal–fetal crosstalk, which is crucial 
for implantation, placentation, remodeling of uterine 
vasculature, and development of maternal immune 
tolerance (Nair et al. 2017). The placenta works as an 
endocrine organ that produces growth factors, steroids, 
peptide hormones and cytokines that are important 
for the establishment and maintenance of pregnancy. 
Several cytokines and growth factors, such as leptin, are 
known to control trophoblast migration, proliferation 
and invasion (Dos Santos et al. 2015).
Leptin is a non-glycosylated peptide of 146 amino 
acid residues (16 kDa), found to be secreted by adipose 
tissue (Zhang et al. 1994), with the important function 
of regulating satiety and energy homeostasis (Farooqi 
& O’Rahilly 2014). Abundant evidence also linked 
leptin with reproductive functions, such as fertility, 
ovarian function regulation, embryo development 
and implantation (Henson & Castracane 2006, Perez-
Perez  et  al. 2015). Trophoblast cells synthesize and 
secrete leptin and express its functional receptors 
(Masuzaki et al. 1997, Senaris et al. 1997), suggesting that 
leptin may play paracrine or/and autocrine functions. In 
this way, previous studies have demonstrated that leptin 
modulates the secretion of many placental hormones, 
implicating leptin as a regulator of placental endocrine 
function (Coya et al. 2006). Moreover, leptin stimulates 
cell survival in BeWo and JEG-3 human trophoblastic cell 
lines, enhancing cell proliferation and protein synthesis, 
and inhibits cell death by apoptosis (Magarinos  et  al. 
2007, Perez-Perez et al. 2008, 2009, 2010).
Leptin metabolism and function alterations in 
the placenta are linked to different disorders during 
pregnancy, such as gestational diabetes, intrauterine 
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growth restriction, recurrent miscarriage, and 
preeclampsia (Howell & Powell 2017, Briana & 
Malamitsi-Puchner 2020, Subiabre et al. 2020). Leptin 
levels are also elevated in obese pregnant women 
correlating with more pronounced insulin resistance 
and activation of mTOR signaling in the placenta, that 
might contribute to fetal overgrowth and adiposity in the 
offspring (Kelly et al. 2020).
Leptin expression in the placenta is strictly regulated 
and there are differences between the transcriptional 
regulation of human placental and adipose leptin 
(Coya  et  al. 2001). The human leptin gene has at 
−1.9 kb an enhancer that is activated by placental-
specific transcription factors (Bi  et  al. 1997). We have 
previously published data confirming that estradiol, a 
key regulator during pregnancy, upregulates placental 
leptin expression (Gambino et al. 2010).
Steroids are key players in the development and 
maintenance of the placenta (Noyola-Martinez  et  al. 
2019). The dominant estrogen in humans is 17β-estradiol 
(E2) (Bjornstrom & Sjoberg 2005). During cytotrophoblast 
invasion, placenta growth and throughout pregnancy 
there is a tightly estrogen synthesis regulation (Everett 
& MacDonald 1979). Moreover, placenta derived 
estrogens play an autocrine regulation in trophoblast 
differentiation and gestational uterine vascular 
remodeling (Albrecht  et  al. 2006, Mandala 2020). 
Besides, estrogen receptors (ER) ERα and β proteins 
have been immunolocalized in nuclei of cultured term 
human placental syncytiotrophoblast cells (Billiar et al. 
1997). Estradiol exerts its effect through genomic and 
nongenomic mechanisms. In the classical response, 
estradiol binds to its ER and generates the dimerization 
of the receptor, the translocation to the nucleus and the 
association with coactivators or corepressors that regulate 
transcription through the binding to its target genes 
(Nilsson et al. 2001). In previous works (Gambino et al. 
2012a,b), we have reported that E2 upregulates leptin 
expression in human placental cells by genomic and 
nongenomic mechanisms involving a crosstalk between 
ERα and MAPK or PI3K signal transduction pathways. 
ERα might be phosphorylated on multiple sites, and the 
activation of different protein kinases can lead to ligand 
independent ERα transcriptional promotion (Lannigan 
2003). Gene expression regulation by ER complex 
might also involve the participation of other DNA-
bound transcription factors such as AP-1, Sp1, NFκB and 
p300 (Safe & Kim 2008). Moreover we have previously 
described a cooperative behavior between ERα and Sp1 
transcription factors to induce leptin transcription in 
placental cells (Schanton et al. 2018).
The nuclear factor kappa B (NFκB) is a transcription 
factor that regulates gene expression of targets associated 
to inflammation and immune response (Taniguchi 
& Karin 2018). The NFκB family consists of different 
DNA-binding proteins that form diverse homodimers 
and heterodimers, being the best characterized at 
present the p65 (Rel A)/p50 hetero-complex (Perkins 
2012). Inactive NFkB is associated with IkB inhibitor 
proteins. Specific kinases, activated by extracellular 
signals, phosphorylate IkB and mark it for degradation, 
allowing the translocation to the nucleus and activation 
of NFkB complex (Ghosh & Karin 2002). In addition to 
its central role in immune response and inflammation, 
NFkB regulates the expression of genes that control cell 
viability (Monkkonen & Debnath 2018). In mammals, 
NFκB is considered a key player in the establishment 
of the implantation window and in the initiation of 
labor (King  et  al. 2001, Lappas & Rice 2007). In this 
context, NFκB expression is tightly regulated to sustain 
the cytokine profile necessary for the maternal tolerance 
to fetal antigens (McCracken et al. 2004).
Although crosstalk between NFκB and ER has been 
proposed, the mechanism by which NFκB pathway 
regulates ER function has not been fully resolved.
To improve the understanding of ER regulation 
on placental leptin expression, we examined, in this 
work, the effect of inflammatory NFκB signaling on 
leptin expression in human placental cells. Estradiol 
plays a critical role in the control of numerous 
placental hormones and seems to mediate leptin gene 
expression in placenta. We hypothesized that NFκB 
transcription factor participates in estradiol leptin 
expression regulation. Our study contributes with data 
demonstrating that NFκB enhances leptin expression 




Written informed consent was obtained from all subjects 
and all study procedures were approved by ethical 
review committee at the Alejandro Posadas National 
Hospital (Bioethics Committee ‘Dr. Vicente Federico del 
Giudice’).Cell culture and treatments
BeWo, a human choriocarcinoma cell line, was 
acquired from the American Type Culture Collection 
(ATCC). They were grown in 45% Dulbecco modified 
Eagle medium (DMEM) and 45% HAM F-12 
(Invitrogen), 100 U/mL penicillin, supplemented with 
10% fetal bovine serum (FBS), 100 U/mL penicillin, 
100 μg/mL streptomycin, 1 mM sodium pyruvate (Sigma 
Chemical Company) and 2 nM glutamine (Invitrogen), 
at 37°C in 5% CO2. Cell medium was replaced after 
24 h of incubation, with DMEM-F12 0% or 1% FBS, 
later on, the cells were treated for 48 h for total protein 
immunoblotting or during shorter time laps for protein 
phosphorylation determination.
Optimal 17β-estradiol (E2) (Sigma) concentrations were 
previously determined. In total, 10 or 100 nM E2 was used. 
(Gambino et al. 2010). The specific Iκκ inhibitor sulfasalazine 
(Wahl  et  al. 1998) was used in different concentrations (10, 
100 and 1000 nM) during 48 h.
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BeWo cell line was also incubated with phorbol 12-myristate 
13-acetate (PMA) (100 ng/mL). Afterwards, cells were washed 
with PBS and solubilized in lysis buffer (1% Nonidet P-40, 
0.5% sodium deoxycholate, 0.1% sodium dodecyl sulfate 
(SDS), 1× PBS and 10 mg/mL phenylmethanesulfonyl fluoride 
(PMSF)). Western blot was performed with cell lysates. E2 
treatment was carried out in DMEM/F-12 media deprived of 
phenol red and supplemented with 1% charcoal stripped FBS 
unless indicated.
Placental explants collection and processing
Human placentas (n = 16) at term were acquired from 
normal pregnant woman after delivery. Villous tissue free 
of calcification, hematoma or visible infarct, was sampled 
from different cotyledons a distance equidistant between the 
chorionic and basal plates. These parts of the cotyledons were 
cut into several cubic fragments (10–15 mg) and meticulously 
rinsed with cold DMEM-F12 0% FBS medium.
Treatment of placental explants
To represent a more physiological model, placental explants 
were incubated during 24 h with different treatments as 
indicated in each figure.
Placental explants were distributed in plates of 24 wells 
containing 1 mL of DMEM 0% FBS (n = 1 explant/well, two 
replicates per treatment), maintained at 37°C during 30 
min to equilibrate temperature, and incubated for 24 h in 
DMEM-F12 0% FBS in the presence or not of E2. The explants 
were removed, centrifuged for 2 min at 2000 g at 4°C and 
suspended in 300 μL of lysis buffer (1% Nonidet P-40, 0.5% 
sodium deoxycholate, 0.1% sodium dodecyl sulfate (SDS), 
1× PBS and 10 mg/mL phenylmethanesulfonyl fluoride 
(PMSF)) for 30 min at 4°C on an orbital shaker. Later, they 
were centrifuged at 10,000 g for 20 min. Western blot test was 
performed with the supernatants.
For qRT-PCR, after washing with PBS, the explants were 
frozen at −80°C and stored until extraction of total RNA.
Western blot
Complete cell lysates were prepared in lysis buffer. The 
lysates were centrifuged at 10,000 g for 10 min to remove 
cellular debris. The protein concentration of the supernatant 
was determined by the colorimetric method BCA Protein 
Assay Kit (Pierce, Thermo Scientific). Lysates were mixes 
with Laemmli’s sample buffer having 2% SDS and 30 mM 
β-mercaptoethanol, boiled for 5 min, resolved by SDS-
PAGE on a 12% gel, and electrophoretically transferred to 
nitrocellulose membrane (Hybond, Amersham Pharmacia). 
Membranes were equilibrated in 1× PBS and non-specific 
binding sites were blocked with 5% non-fat milk in PBS at 
room temperature for 1 h. Then they were immunoblotted with 
the specific polyclonal rabbit anti-human leptin Y20 (1:1000, 
Santa Cruz Biotechnology, Inc.), monoclonal mouse anti-p65 
(1:1000, Santa Cruz Biotechnology, Inc.), or monoclonal 
mouse anti-pIκBα (1:1000 Santa Cruz Biotechnology, Inc.). 
Loading controls were done by immunoblotting the same 
membranes with monoclonal mouse anti-α-tubulin (1:1000, 
Santa Cruz Biotechnology, Inc.) or monoclonal mouse anti 
glyceraldehyde-3-phospate dehydrogenase (GAPDH) (1:1000, 
Santa Cruz Biotechnology, Inc.). The detection of the antibodies 
was made using horseradish peroxidase-linked goat anti-mouse 
IgG or anti-rabbit IgG (1:1000, Sigma and Co.), visualized by 
the Amersham Pharmacia ECL Chemiluminescence signaling 
system and a Bio-Imaging Analyzer G-box Chemi XT4 
(Syngene). The quantification of protein bands was analyzed 
by densitometry using the software Image J version 1.45 (NIH).
Plasmids
Dr Oksana Gavrilova (Bi et al. 1997) generously provided the 
luciferase reporter construct, based on the PGL-3 basic vector. 
This vector contains a fragment of leptin promoter region 
upstream of the luciferase (Luc) reporter gene, which codify for 
the luciferase enzyme. The plasmid was renamed indicating 
the number of base pairs upstream of transcription initiation 
site: pL1951/42 (−1951 to +42 bp of leptin promoter). The 
expression plasmids HEGO and Rel A contain the cDNA of ERα 
and the subunit p65 of NFκB, respectively (provided generously 
by Dr Adali Pecci, Facultad de Ciencias Exactas y Naturales, 
Universidad de Buenos Aires, Buenos Aires, Argentina). 
The pNFκB vector is a reporter plasmid that contains NFκB 
binding elements upstream a minimal promoter and the Luc 
reporter gene.
The efficiency of individual transfections was normalized 
using the pRSV-βgal vector containing the β-galactosidase gene 
under the control of the Rous sarcoma virus (RSV) promoter. The 
empty vector was used as control in transfection experiments 
with expression plasmids. Plasmids were purified using the 
Midiprep Wizard kit (Promega), and DNA concentration was 
estimated spectrophotometrically.
Transient transfection experiments
BeWo cells were plated in to six-well dishes containing 
1 mL of DMEM-F12 10% FBS, at a density of 2.5 × 105 cell/
mL, during 24 h. Normally, 5 μg of the pRSV-βgal, 5 μg of the 
luciferase reporter and 5 μg of each expression plasmid were 
transfected using 7,5 μL of PEI 2 mg/mL (Polyethylenimine, 
Polysciences, Inc). After 4 h the medium was replaced with 
DMEM-F12 1% FBS with the addition of the different treatments 
as statement in the corresponding legend. Each experiment 
was made in duplicate and it was performed at least three 
independent times.
Assay for luciferase and β-galactosidase activities
Luciferase Assay System (Promega) was used to measure 
luciferase (Luc) activity in cell lysates. Seventy-two 
hours after transfection, cells were washed with PBS and 
harvested using 50 μL of lysis buffer provided by the 
manufacturer. GloMaxMulti + Microplate Multimode Reader 
Luminometer (Promega) was used to measure luciferase 
activity. β-Galactosidase activity was assayed using 1 mg 
of o-nitrophenyl β-d-galactopyranoside (AmResco) as the 
substrate in buffer Z (40 mM NaH2PO4, 60 nM Ns2HPO4, 
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10 nM KCl, 0.07% β-mercaptoethanol, 1 mM MgSO4). Samples 
were incubated at 37°C until yellow staining. Enzymatic 
reaction was stopped with 75 μL of sodium carbonate. Color 
development was determined by absorption at 420 nm. The 
variation in transfection efficiency was corrected with this 
value. Luc results were calculated as the percentage of Luc 
activity per unit of β-galactosidase activity. For each data 
duplicates were performed.
Quantitative real-time RT-PCR (qRT-PCR) assay
Quantity of leptin mRNA was determined by qRT-PCR. 
TRISURE reagent was used to extract total RNA according to 
the manufacture instructions (Bioline Co). The concentration 
and purity of the RNA were estimated spectrophotometrically 
at 260 and 280 nm. For the synthesis of cDNA, 5 μg of total 
RNA was reverse transcribed at 55°C during 1 h using the fist 
Strand cDNA synthesis Kit (Roche). The following primers based 
on the sequences of the National Center for Biotechnology 
Information GenBank were used for quantitative real-time 
PCR: Leptin: forward 5′-GAACCCTGTGCGGATTCTT-3′; 
reverse 5′-CCAGGTCGTTGGATATTTGG-3′; and Cyclophilin: 
forward, 5′-CTTCCCCGATGAGAACTTCA-3′; reverse, 
5′-TCTTGGTGCTCTCCACCTTC-3′. qRT-PCR Master Mix 
Reagent kit was obtained from Roche (Fast Start universal 
SYBR Green), and PCRs were performed on a Chromo 4 DNA 
Engine (BioRad).
The reaction contains 10 μM of forward and reverse primers, 
3 μL of cDNA, and the final reaction volume was 25 μL. The 
reaction initiated by preheating at 50°C for 2 min, followed 
by heating at 95°C for 10 min. Subsequently, 41 amplification 
cycles were carried out as describes: denaturation 15 s at 
95°C and 1 min annealing and extension 1 min at 59°C. The 
threshold cycle (CT) from each well was calculated by the 
Opticon Monitor 3 Program. The 2−ΔΔCT method was used to 
calculate the relative quantification (Livak & Schmittgen 2001). 
The evaluation of 2−ΔΔCT for treated samples indicates the fold 
change in gene expression, normalized to a housekeeping gene 
(cyclophilin), and relative to the untreated control. To confirm 
the specificity of amplification a melting curve analysis was 
performed. To ensure the absence of sample contamination, 
reaction mixtures without reverse transcriptase or RNA were 
run in parallel.
Immunofluorescence assays
Bewo cells were grown on coverslips in DMEM-F12 10% 
FBS. The next day they were transiently transfected with Rel 
A and/or HEGO expression plasmids and were treated with 
100 nM estradiol at the times indicated in the figures. Then 
they were washed three times with PBS, fixed 20 min with 3% 
p-formaldehyde and permeabilized with 0.1% Triton X-100 as 
described (Quinta et al. 2010). After the fixation, the cells were 
washed three times with PBS, and blocked for 30 min with AFI 
solution (BSA 0.5%, Tween 20 0.2%, sodium azide 0.1%, Tris 50 
nM pH 8). The primary antibodies were diluted in AFI solution 
and were added to the cells ON at 4°C: rabbit polyclonal anti-
ERα (1:50, Santa Cruz Biotechnology) or mouse monoclonal 
anti-Rel A (1:100 Santa Cruz Biotechnology). This incubation 
was followed by three washes with PBS for 10 min and then 
the cells were incubated with the secondary antibodies for 
1 h: Alexa 488 nm anti rabbit IgG (1:100, Thermo Fisher) or 
Alexa 563 nm anti mouse IgG (1:100, Thermo Fisher). After 
further washings with PBS and counterstained with DAPI, 
samples were mounting with prolong Gold antifading solution 
(Thermo Scientific). The images were taken using an inverted 
fluorescence microscope (Nikon) and analyzed using the 
software Image J version 1.45 (NIH).
Immunoprecipitation assays
After E2 treatment, cells were washed two times with PBS, 
scrapped, and homogenized in HEM buffer (1 nM EDTA, 10 mM 
Hepes buffer at pH 7.4 and 20 mM Na2MoO4). After a 
centrifugation for 10 min at 4°C at 12,000 g, ERα and p65 
were immunoprecipitated from 300 μL of cytosol (4 mg/mL 
protein), with 2 μL of anti-ERα or anti-Sp1 antibody and 30 μL 
of 50% (g/v) protein A-Sepharose (Sigma) under rotation for 
3 h at 4°C. Pellets were washed five times with 1 mL of HEM 
buffer, and proteins were detected by Western blotting (0.05%, 
v/v dilution for primary antibodies and 0.02%, v/v dilution 
for horseradish peroxidase-labeled secondary antibody 
anti-rabbit). Antibodies were visualized by the Amersham 
Pharmacia ECL Chemiluminescence signaling system and a 
Bio-Imaging Analyzer G-box Chemi XT4 (Syngene).
Statistical analysis
To assure reproducible results experiments were repeated 
separately at least three times. In Western blot analysis arbitrary 
units were calculated from normalized bands intensity, and in 
reporter assays from normalized Luc activity. Controls values 
were set as 1. ANOVA followed by different post hoc tests, 
was used to assess statistical significance as indicated in each 
figure. A P-value <0.05 was considered statistically significant.
Results
NFκB inhibition blocked E2 effect on leptin expression
It was extensively reported that ERα gene expression 
regulation could be mediated by the crosstalk with 
different transcription factors (Safe & Kim 2008). In this 
regard, we aimed to study NFκB signaling pathway on E2 
induced leptin expression in placental cells. Sulfasalazine, 
a potent and specific inhibitor of both transcription and 
nuclear translocation of the inflammatory transcription 
factor NFκB (Wahl et al. 1998), was used. Treatment with 
sulfasalazine 10, 100 and 1000 nM completely blocked 
E2 induction of leptin expression determined by qRT-PCR 
in BeWo cells (Fig. 1A). Similar results were obtained 
when sulfasalazine effect was assessed on human term 
placental explants, a more physiological model (Fig. 1B). 
All these results were validated by Western blot analysis 
both in BeWo cells and placental explants (Fig. 1C 
and D). Moreover, in placental explants, sulfasalazine 
treatment decreased endogenous leptin, suggesting 
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that NFκB pathway could be involved in basal leptin 
expression regulation (Fig. 1D).
Crosstalk between p65 and ERα on leptin expression
To analyze a putative cooperation between ERα and p65 
transcription factors on placental leptin transcription, 
different approaches were performed. First, transient 
transfection experiments with different amounts of p65 
(Rel A) expression vector and 100 nM E2 treatment, were 
performed in BeWo cells. Reporter transcription was 
evaluated using the pL1951/42 plasmid construction 
that contains leptin promoter region from −1951 to 
+42 bp directing luciferase (Luc) expression. As it is 
seen in Fig. 2A 100 nM E2 significantly increased leptin 
expression as already published (Gambino et al. 2010). 
The overexpression of the human transcription factor 
p65, with 0.5 µg plasmid, significantly enhanced basal 
leptin expression in BeWo cells. On the other hand, p65 
overexpression did not alter E2 effect on leptin promoter 
transcription.
Second, to further study the effect between estradiol, 
ERα and p65 transcription factors on leptin expression, 
similar transient transfection experiments were 
performed using p65 (Rel A) and ERα (HEGO) expression 
vectors. The transfection of 0.5 µg of Rel A plasmid 
significantly increased leptin expression as described 
earlier. The cotransfection with 10 ng of ERα expression 
vector significantly increased leptin expression but did 
not differ from the increase obtained with Rel A alone 
(Fig. 2B). It is worthy to notice that very small quantities 
of HEGO plasmid were used to not saturate the system.
Figure 1 Inhibition of NFκB suppressed E2 effect on leptin expression BeWo cells (A) and (C) and term placental explants (B) and (D) were 
pretreated as indicated with sulfasalazine during 30 min, afterwards E2 was added. After 48 h (A) or 24 h (B), total RNA was extracted and Leptin 
mRNA expression was quantified by qRT-PCR. Cyclophilin was used as internal standard. Cell extracts (C) and placental explants extracts (D) 
were prepared as indicated in ‘Materials and methods’ section and proteins were separated on 12% SDS-PAGE gel. Leptin expression was 
determined by Western blot. Loading control was performed by immunoblotting the same membranes with anti-GAPDH. Standard protein 
markers were used to estimate the molecular weights. Molecular weight (kDa) is indicated at the right of each blot. Bands densitometry is shown 
in lower panels. Results are expressed as mean ± s.d. for ten independent experiments. *P < 0.05, **P < 0.01, ***P < 0.001 vs control and ##P 
< 0.01, ###P < 0.001 vs E2 treatment. Statistical analyses were performed by ANOVA followed by Bonferroni post hoc test.
Downloaded from Bioscientifica.com at 10/07/2021 07:47:16PM
via free access
 https://rep.bioscientifica.com
M Schanton and others596
Reproduction (2020) 160 591–602 
In a third approach, BeWo cells with ERα 
downregulated expression were generated using siRNA 
strategy. Cells were stably transfected with an inducible 
expression plasmid encoding a precursor RNA that 
after processing maturates in a siRNA against ERα. This 
cell line called BeWo-Sh2 was cotransfected with the 
pL1951/42 reporter vector and Rel A expression plasmid. 
The transcription of ERα siRNA was induced with 
doxycycline and Luc activity was determined after 48 h. 
We observed that the downregulation of ERα abolished 
Rel A induction of leptin expression suggesting that ERα 
is necessary to evidence p65 inductive effect (Fig. 2C). 
In these cells E2 induction of leptin expression is lost 
as expected. As a positive control, an experiment was 
performed in BeWo-Sh2 cells in which doxycycline 
was omitted corroborating the inductive effect of E2 on 
the leptin reporter plasmid pL1951 (Fig. 2C inset). All 
these results suggest a regulatory effect of NFκB pathway 
activation on estradiol leptin expression regulation.
Estradiol increased NFκB signaling pathway activation 
in trophoblastic cells
The effect of E2 on different steps of NFκB signaling 
pathway activation was analyzed. Reported data 
show that the expression of the Rel A protooncogene 
could be regulated in invasive cells (Dominska  et  al. 
2017). Considering that first trimester extravillous 
cytotrophoblast are prone to proliferate and invade the 
decidua and the fact that estrogens promote growth, the 
aim of the present experiment was to evaluate changes 
in the expression of NFκB Rel A proto-oncogene p65 
subunit. The addition of 10 and 100 nM E2 significantly 
increased p65 expression in BeWo cells after 48 h 
of treatment. No changes in the expression of p65 
were observed at 24 h of treatment (Fig. 3A). Similar 
experiments were performed in a more physiological 
model, using term human placental explants. In this 
model, the incubation with 100 nM E2 during 24 h 
significantly increased p65 expression (Fig. 3B).
On the other hand, in the NFκB signaling pathway, 
extracellular factors interact with cell surface receptors 
and cause the release of active NFκB from phosphorylated 
Figure 2 Effect of p65 overexpression on E2 induced placental leptin 
expression. (A) BeWo cells were transiently transfected with pL1951 
plasmid construction containing the promoter region of leptin gene 
from −1951 to +42 bp and different amounts of p65 expression 
plasmid. After transfection, BeWo cells were incubated for 48 h in 
DMEM-F12 media supplemented with 1% FBS and treated with E2 as 
indicated. (B) BeWo cells were transiently transfected with pL1951 
plasmid construction, different amounts of plasmid expressing human 
ERα (HEGO) and p65 expression plasmid. After transfection, cells 
were incubated for 48 h in DMEM-F12 media supplemented with 1% 
FBS. (C) BeWo-Sh2 cells were transiently transfected with pL1951/42 
plasmid construction and Rel A expression plasmid and treated with 
different doses of E2, and with 5 mg/mL of doxycycline, to induce the 
expression of the ERα interference RNA. Cells were incubated for 48 
h in DMEM-F12 media supplemented with 1% FBS. As control, 
doxycycline was omitted, corroborating the inductive effect of E2 on 
the pL1951/42 vector (inset figure). (A–C) Cell extracts were prepared 
as indicated in ‘Materials and methods’ section, Luc activity was 
measured in the cellular extracts and normalized to β-galactosidase 
activity. Results are expressed as mean ± s.d. for four independent 
experiments. *P < 0.05, **P < 0.01, ***P < 0.001 vs control. 
Statistical analyses were performed by ANOVA followed by 
Bonferroni post hoc test.
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cytoplasmic inhibitory protein κB (IκB). The next 
challenge was to determine the phosphorylation of IκBα 
in response to E2 stimulation. Treatment with 100 nM E2 
during 15 min significantly increased pIκBα (Fig. 3C). 
Positive control of IkBα phosphorylation was performed 
by the incubation of BeWo cells with the phorbol ester 
phorbol 12-myristate 13-acetate (PMA), a well-known 
stimulator of NFκB signaling. The addition of 100 ng/mL 
of PMA produced a significant enhancement of pIκBα 
at 5 min incubation as expected (Fig. 3C inset). The 
phosphorylation of IκBα was also significantly increased 
after 24 h of treatment with 100 nM E2 in term human 
placental explants (Fig. 3D).
Finally, to analyze the putative involvement of E2 
treatment on NFκB target gene activation, transient 
transfection experiments with an NFκB reporter 
construction were performed. The reporter plasmid 
contains multiple binding sites for NFκB dimers 
regulating Luc expression. Treatment with 100 nM 
E2 significantly stimulated Luc expression (Fig. 3E). 
A positive control was included incubating BeWo 
cells with 100 ng/mL PMA. In this case a significant 
induction of Luc expression was observed as expected 
(Fig. 3E inset).
Localization and interaction of ERα and p65 in 
placental cells
To further study a possible crosstalk between the 
estradiol and NFκB signaling pathways, localization 
experiments were performed. In control cells, there 
was a homogeneous distribution of endogenous ERα 
or p65 proteins within the cytoplasm and nucleus 
(Fig. 4A). Estradiol treatment during 180 min induced 
endogenous ERα and p65 proteins to a perinuclear 
localization. Similar results were obtained when p65 
protein was overexpressed. In addition when p65 
protein was overexpressed and cells were treated with 
estradiol during 180 min nuclear p65 localization was 
induced. Moreover the overexpression of ERα produced 
Figure 3 Estradiol increased NFκB signaling pathway activation in trophoblastic cells. BeWo cells (A) and placental explants (B) were treated 
with 10 and 100 nM E2 as indicated, during 24 and 48 h (A) or 24 h (B). Proteins were separated on 12% SDS-PAGE gels and p65 expression 
was determined by Western blot. (C) BeWo cells were treated with 100 nM E2 during 0, 5, 15, 25 min. As control BeWo cells were treated with 
100 ng/mL phorbol 12-myrisate 13-acetate (PMA) in the same conditions (inset figure). Proteins were separated on 12% SDS-PAGE gels and 
IκBα phosphorylation (pIκBα) was determined by Western blot. (D) Placental explants were incubated with 10 and 100 nM E2 during 24 h. 
Proteins were separated on 12% SDS-PAGE gels and IκBα phosphorylation (pIκBα) was determined by Western blot. (A–D) Protein extracts were 
prepared as previously described in ‘Materials and methods’ section. Loading control was performed by immunoblotting the same membranes 
with anti-GAPDH or anti-α-Tubulin. Standard protein markers were used to estimate the molecular weights. Molecular weight (kDa) is indicated 
at the right of each blot. Bands densitometry is shown in lower panels. (E) BeWo cells were transiently transfected with pNFκB reporter plasmid 
construction, and treated with 100 and 10 nM E2 as indicated. As control BeWo cells were incubated with 100 ng/mL phorbol 12-myrisate 
13-acetate (PMA) (inset figure). Cell extracts were prepared as indicated in ‘Materials and methods’ section and Luc activity was measured in the 
cellular extract and normalized to β-galactosidase activity. Results are expressed as mean ± s.d. of six independent experiments. *P < 0.05,  
**P < 0.01, ***P < 0.001 vs each control. Statistical analyses were performed by ANOVA followed by Bonferroni post hoc test.
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a complete displacement of both endogenous and 
overexpressed p65 protein to the nuclear localization. 
Estradiol treatment in the ERα and p65 overexpression 
condition did not modify nuclear localization of these 
two proteins. All these results prompted us to study a 
possible interaction between ERα and p65 proteins. 
To analyze this hypothesis immunoprecipitation 
experiments were performed. BeWo cells were 
treated with 100 nM E2 and endogenous ERα was 
immunoprecipitated to study the putative interaction 
with p65 in physiological condition. Protein p65 was 
revealed in the immunoprecipitate by Western blot. The 
presence of p65 in the ERα immunoprecipitate indicates 
that both proteins are present together in a complex. 
Previous unpublished results from our lab have shown 
an association between ERα and Sp1 transcription factor. 
To unravel the possibility that these proteins participate 
in the same complex Sp1 immunoprecipitation 
experiments were performed. P65 is not present in the 
Sp1 immunoprecipitate (Fig. 4B). These results strongly 
suggest that ERα is probably participating in different 
specific complexes with p65 or Sp1 proteins.
Discussion
The regulation of leptin expression in placenta is 
modulated by steroid hormones, glucocorticoids and 
insulin (Coya et al. 2001, Perez-Perez et al. 2013). It was 
Figure 4 Localization and interaction of ERα and p65 in placental cells. (A) BeWo cells were seeded on coverslips in six-well plates and 
incubated in DMEM 1% FBS with estradiol 100 nM (E2) or without E2 (CONTROL) during 3 h. Also, BeWo cells were transiently transfected with 
human ERα (HEGO) and p65 (Rel A) expression plasmids, and treated or not with 100 nM E2, as indicated, during 3 h. Cells were fixed and ERα 
expression (green) was detected using Alexa 488 conjugated secondary antibody and p65 expression (red) was detected with Alexa 568 
conjugated secondary antibody. The nuclei were stained with DAPI (blue). Scale bar: 8 μm. Representative results from four replicates are 
shown. Representative micrographs from BeWo at 60X are shown. (B) BeWo cells were treated with 100 nM estradiol (E2) during 24 h and 
whole cell extract (Input) was prepared as indicated in ‘Materials and methods’ section. Endogenous ERα or Sp1 were immunoprecipitated from 
whole cell extract with a specific IgG (I) or a non-immune IgG (NI), and p65 or ERα were revealed by Western blot as indicated. Representative 
results from two replicates are shown.
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also demonstrated that human leptin gene is enhanced by 
hypoxia through mechanisms common to other hypoxia-
inducible genes (Ambrosini et al. 2002). Moreover, we 
have previously shown that leptin expression in placenta 
is upregulated by very important pregnancy signals 
such as cAMP, hCG and E2 (Maymo et al. 2009, 2010, 
2012, Gambino  et  al. 2010). In the present work, we 
have studied the mechanisms involved in the regulation 
of leptin expression by E2 and NFκB signaling pathway 
in BeWo human choriocarcinoma cells. These cells 
express both leptin and its receptor (Magarinos  et  al. 
2007). Term human placental explants were also used to 
validate results in a more physiological model.
NFκΒ is a multifunctional transcription factor and 
modulates the expression of genes that influence cell 
cycle progression, cell death regulation by apoptosis, 
inflammatory reactions, immune response and 
metastasis. In this way, both ER and NFκΒ can induce 
expression of growth and survival genes by a crosstalk at 
the transcriptional level.
To asses NFκΒ incidence on leptin expression inhibitory 
experiments with sulfasalazine were done. Sulfasalazine 
is a potent and specific inhibitor of both transcription and 
nuclear translocation of the inflammatory transcription 
factor NFκB. The in vitro doses of sulfasalazine we used 
were similar to other studies examining the effect of 
sulfasalazine on the vasculature (Kim et al. 2009) and in 
endothelial and cytotrophoblast cells (Brownfoot et al. 
2019). The pharmacokinetics of sulfasalazine, during 
a normal therapy, in healthy individuals would show 
steady state serum concentrations of around 113 μM 
(Klotz 1985) when administered at 4 g per day. Therefore 
we examined the effect of sulfasalazine in vitro at doses 
straddling this threshold (Wahl  et  al. 1998). Treatment 
with sulfasalazine 10, 100 and 1000 nM, completely 
blocked estradiol action on leptin expression both in 
BeWo cells and placental explants. These results strongly 
suggest that NFκB transcription factor is modulating 
estradiol enhancement of leptin expression. To further 
characterize the effect of NFκB transcription factor, Rel 
A overexpression on leptin transcription was analyzed 
in BeWo cells. A significant upregulation was observed 
using reporter assays with the pL1951/42 construction. 
NFκB activation showed no effect on E2 induction of 
leptin expression in transient transfection assays. At 
higher doses of Rel A plasmid, leptin expression returned 
to control levels regardless of E2 presence. Similar results 
were obtained previously where leptin expression was 
diminished with high concentration of the inductors E2 
(Gambino et al. 2010), hCG (Maymo et al. 2009) or cAMP 
(Maymo et al. 2010). This phenomenon is probably due 
to a saturation of the transcription mechanisms.
In view of these findings the effect of ERα and p65 
transcription factors on leptin expression was analyzed. 
The cotransfection of Rel A with ERα expression vectors 
significantly increased leptin expression but did not differ 
from the increase with Rel A alone. These results might 
suggest that the activation of the NFκΒ transcription 
factor is sufficient to increase leptin expression. To 
elucidate the involvement of ERα in NFκΒ induction 
of leptin expression, transient transfection experiments 
in cells with siRNA silenced ERα were performed. Our 
data show that the downregulation of ERα abolished Rel 
A induction of leptin expression. These results strongly 
suggest that ERα is necessary to evidence p65 inductive 
effect. All these evidences indicate a regulatory effect 
of NFκB pathway activation in cooperation with ER 
signaling on leptin expression. According to the ‘classical 
genomic model’ ligand-activated ERα binds to specific 
ERE to modulate transcriptional activity of E2 target 
genes. Nevertheless, 35% of the categorized human E2 
responsive genes are transcribed via indirect ER-DNA 
association through protein–protein interactions 
with several trans factors such as Sp1, NFκB, or AP-1 
(O’Connor  et  al. 2016). It was also described that ER 
family shares some common coactivators with NFkB, 
such as RAC3 (Klinge 2000). RAC3 is a member of the 
Steroid Receptor Coactivator (SRC) family that increases 
the transcriptional activity of several nuclear receptors 
and NFκB (Sheppard  et  al. 1999). The molecular 
mechanism by which coactivators induce chromatin 
remodeling and transcriptional activation involves a 
histone acetyltransferase (HAT) activity, present in RAC3 
(Glass & Rosenfeld 2000) and the recruitment of other 
general coactivators such as CBP/p300 (Chen  et  al. 
1999).
Crosstalk between the NFκΒ and ER pathways 
participates in the regulation of many cellular processes, 
for instance, both estrogen and active NFκΒ stimulate 
cell proliferation mediated by increased expression of 
the cell cycle regulatory protein cyclin D1. In this gene 
regulation, estrogenic signaling through ER modulates 
NFκB activation, in a manner that appears to be 
independent of gene transcription (Biswas et al. 2005). 
Therefore, the crossroads of these two pathways is 
important in cells that simultaneously carry both routes 
such as trophoblastic cells.
In view of this data, activation of the NFκΒ pathway by 
ER signaling was studied. Treatment with E2 significantly 
increased p65 expression and phosphorylation of IκBα 
in BeWo cells and term human placental explants. 
These results support the hypothesis that ER signaling 
increases NFκΒ activation. To confirm this data a 
transient transfection assay was performed with a NFκB 
reporter construction. In these experiments, significant 
stimulation of Luc expression was observed after E2 
treatment. These results showed that NFκΒ signaling 
activation was evidenced at the transcriptional level.
In this work, our data support a mechanism activated 
by NFκΒ to induce leptin expression in coordination 
with ERα in placenta. It was seen that ERα could 
complex with different transcription factors to modulate 
transcription. For instance ERα and Sp1 interact in 
vivo to mediate E2 induced activation of kisspeptin 1 
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gene in hypothalamic GT-1 cells (Li  et  al. 2007), and 
the integral membrane protein Claudin-5 (Burek  et  al. 
2014), among other genes. Indeed, we have previously 
seen that ERα and Sp1 physically interact in BeWo 
trophoblastic cells (unpublished results). To analyse a 
possible regulatory interaction between ERα and NFκΒ, 
localization and immunoprecipitation experiments were 
performed. Similar localization pattern was observed 
after E2 treatment of overexpressed ERα or p65 BeWo 
cells, suggesting a coordinated regulation. Moreover 
the presence of a complex between ERα and p65 was 
evidenced in trophoblastic cells. This complex differs 
with the one described previously between ERα and 
Sp1, suggesting the formation of different transcription 
factors associations modulating leptin expression.
A considerable body of experimental evidence 
suggests a strong association between NFκB and the 
development of pregnancy. NFκB is an important 
regulator of implantation, and plays a relevant role in 
the induction of parturition induction (Sakowicz 2018). 
On the other side, both leptin and NFκB were described 
as central nodes of action within a complex network 
aimed at preparing for pregnancy, particularly, they 
play an important role in Th1-Th2 immune modulation 
required for successful pregnancy (Faustmann  et  al. 
2016). Moreover, an association between leptin and 
increased cardiovascular risk and increased levels of 
inflammatory factors have been reported in obesity 
(Wang & Nakayama 2010). In this pathology, leptin has 
pro-inflammatory action, involving pro-inflammatory 
cytokines expression, elevated ERK1/2 phosphorylation 
followed by increased NFκB activation and TNFα 
secretion (Lappas et al. 2005, Indra et al. 2013). On the 
other side, NFκB activation is detected in inflammatory 
diseases that are associated with increased amounts 
of inflammatory cytokines (Lawrence 2009). Some of 
these cytokine’s genes are direct targets that are both 
expressed in response to NFκB activation and can feed-
forward to activate NFκB by causing release of NFκB 
from IκB. This effect can amplify the immune response 
and prolong inflammation, either in a physiologic 
response or in a disease state. This positive feedback 
mechanism could give an explanation of NFκB effect on 
estradiol leptin expression. Undoubtedly, further studies 
are required to examine the interaction between the 
members of the NFκB transcription factor gene family 
and ERs in placental cells. On the other hand it has 
been postulated that maternal obesity and gestational 
diabetes may be associated with a state of chronic and 
low-grade inflammation termed ‘metainflammation’, 
where the placenta ‘senses’ and adapts to the maternal 
inflammatory environment (Pantham  et  al. 2015). 
In this manner, leptin could be acting as an 
inflammatory mediator.
In summary, in this study, we provide evidence that 
NFκB induces leptin expression in cooperation with 
E2 action through ERα. The molecular mechanism of 
regulation of placental leptin expression by E2 could 
be a multifactorial process, and may depend on the 
localization and concentration of ERs, the association 
with transcription factors such as NFκB and co-regulatory 
proteins and the activation of signal transducers.
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